Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 11th. Analysts expect the company to announce earnings of ($0.21) per share for the quarter. Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) last issued its quarterly earnings results on Thursday, March 30th. The company reported […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research report issued on Friday, Benzinga reports. They presently have a $18.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 110.53% from the stock’s current price. Fennec Pharmaceuticals Trading Up […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) released its quarterly earnings results on Thursday. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.24) by ($0.02), Yahoo Finance reports. Fennec Pharmaceuticals Price Performance Shares of FENC opened at $8.55 on Friday. The company has a market capitalization of $225.81 […]
Shares of Fennec Pharmaceuticals Inc. (TSE:FRX – Get Rating) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$6.62 and traded as high as C$7.52. Fennec Pharmaceuticals shares last traded at C$7.52, with a volume of 106 shares. Separately, Maxim Group reaffirmed a […]